KCNK3 Variants Are Associated with Hyperaldosteronism and Hypertension

Hypertension

Volumn 68, Issue 2, 2016, Pages 356-364

  Manichaikul, Ani ^a   Rich, Stephen S ^a   Allison, Matthew A ^c   Guagliardo, Nick A ^b   Bayliss, Douglas A ^b   Carey, Robert M ^b   Barrett, Paula Q ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African Americans; blood pressure; genetic association studies; Hispanic; hyperaldosteronism; hypertension

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNK3; POTASSIUM CHANNEL KCNK9; RENIN; UNCLASSIFIED DRUG; NERVE PROTEIN; POTASSIUM CHANNEL SUBFAMILY K MEMBER 3; TANDEM PORE DOMAIN POTASSIUM CHANNEL;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PULSE PRESSURE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CALIFORNIA; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; LONGITUDINAL STUDY; MIDDLE AGED; PROCEDURES; RISK FACTOR;

ALDOSTERONE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CALIFORNIA; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RENIN; RISK FACTORS;

EID: 84974658533     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07564     Document Type: Article

References (30)

1. Weder AB. Genetics and hypertension. J Clin Hypertens (Greenwich). 2007;9:217-223.
2. Cooper RS. Gene-environment interactions and the etiology of common complex disease. Ann Intern Med. 2003;139(5 pt 2):437-440.
3. Ganesh SK, Chasman DI, Larson MG, et al; Global Blood Pressure Genetics Consortium. Effects of long-term averaging of quantitative blood pressure traits on the detection of genetic associations. Am J Hum Genet. 2014;95:49-65. doi: 10.1016/j.ajhg.2014.06.002.
4. Kato N, Loh M, Takeuchi F, et al; BIOS-consortium; CARDIo GRAMplusCD; LifeLines Cohort Study; InterAct Consortium. Transancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat Genet. 2015;47:1282-1293. doi: 10.1038/ng.3405.
5. Nogueira EF, Gerry D, Mantero F, Mariniello B, Rainey WE. The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol (Oxf). 2010;73:22-29. doi: 10.1111/j.1365-2265.2009.03738.x.
6. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA, Barrett PQ. TASK channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci U S A. 2008;105:2203-2208. doi: 10.1073/pnas.0712000105.
7. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007;66:607-618. doi: 10.1111/j.1365-2265.2007.02775.x.
8. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension. 2003;41:207-210.
9. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-687. doi: 10.1038/ ng.384.
10. Rifkin DE, Khaki AR, Jenny NS, McClelland RL, Budoff M, Watson K, Ix JH, Allison MA. Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis. Am J Hypertens. 2014;27:801-810. doi: 10.1093/ajh/hpt276.
11. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56-65.
12. Mulkey DK, Talley EM, Stornetta RL, Siegel AR, West GH, Chen X, Sen N, Mistry AM, Guyenet PG, Bayliss DA. TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity. J Neurosci. 2007;27:14049-14058. doi: 10.1523/JNEUROSCI.4254-07.2007.
13. Guagliardo NA, Yao J, Hu C, Schertz EM, Tyson DA, Carey RM, Bayliss DA, Barrett PQ. TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. Hypertension. 2012;59:999-1005. doi: 10.1161/ HYPERTENSIONAHA.111.189662.
14. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ, Kathiresan S, O'Donnell CJ, Musone SL, Camargo AL, Drake JA, Levy D, Hirschhorn JN, Vasan RS. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007;49:846-856. doi: 10.1161/01.HYP. 0000258554.87444.91.
15. O'Seaghdha CM, Hwang SJ, Vasan RS, Larson MG, Hoffmann U, Wang TJ, Fox CS. Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart study. BMC Endocr Disord. 2012;12:3. doi: 10.1186/1472-6823-12-3.
16. Westra HJ, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013;45:1238-1243. doi: 10.1038/ng.2756.
17. Heitzmann D, Derand R, Jungbauer S, et al. Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J. 2008;27:179-187. doi: 10.1038/sj.emboj.7601934.
18. Jaisser F, Farman N. Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology. Pharmacol Rev. 2016;68:49-75. doi: 10.1124/pr.115.011106.
19. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M, Young WF, Jr. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016:jc20154061.
20. Vasan RS, Evans JC, Larson MG, Wilson PW, Meigs JB, Rifai N, Benjamin EJ, Levy D. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med. 2004;351:33-41. doi: 10.1056/NEJMoa033263.
21. Ganesh SK, Zakai NA, van Rooij FJ, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet. 2009;41:1191-1198. doi: 10.1038/ng.466.
22. Jiang W, Yu W. Power estimation and sample size determination for replication studies of genome-wide association studies. BMC Genomics. 2016;17(suppl 1):3. doi: 10.1186/s12864-015-2296-4.
23. Jung J, Barrett PQ, Eckert GJ, Edenberg HJ, Xuei X, Tu W, Pratt JH. Variations in the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone production: an exploratory study. J Clin Endocrinol Metab. 2012;97:E2160-E2167. doi: 10.1210/jc.2012-2196.
24. Luft FC, Grim CE, Fineberg N, Weinberger MC. Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation. 1979;59:643-650.
25. Kotchen TA, Guthrie GP Jr, Cottrill CM, McKean HE, Kotchen JM. Low renin-aldosterone in "prehypertensive" young adults. J Clin Endocrinol Metab. 1982;54:808-814. doi: 10.1210/jcem-54-4-808.
26. Bandulik S, Tauber P, Lalli E, Barhanin J, Warth R. Two-pore domain potassium channels in the adrenal cortex. Pflugers Arch. 2015;467:1027-1042. doi: 10.1007/s00424-014-1628-6.
27. Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772. doi: 10.1126/science.1198785.
28. Scholl UI, Stölting G, Nelson-Williams C, et al. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife. 2015;4:e06315. doi: 10.7554/eLife.06315.
29. Scholl UI, Goh G, Stölting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45:1050-1054. doi: 10.1038/ng.2695.
30. Scholl UI, Healy JM, Thiel A, et al. Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype. Clin Endocrinol (Oxf). 2015;83:779-789. doi: 10.1111/ cen.12873.